Methods for enhancing exposure therapy using pairing with Vagus nerve stimulation

US12064563B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12064563-B2
Application numberUS-202318154280-A
CountryUS
Kind codeB2
Filing dateJan 13, 2023
Priority dateJul 2, 2008
Publication dateAug 20, 2024
Grant dateAug 20, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A therapy method (for a patient having post-traumatic stress disorder (PTSD)) includes: providing an exposure event, to the patient, which is related to a traumatic event that contributed to the PTSD; and, during a therapy session which includes the exposure event, applying vagus nerve stimulation (VNS). A therapy method (for a patient having a given disorder, e.g., a phobia disorder or an obsessive-compulsive disorder (OCD) or an addiction disorder) includes: providing a therapy event (e.g., an extinction event for a phobia disorder), to the patient, which is related to one or more things that contributed to the given disorder; and during a therapy session which includes the therapy event, applying VNS.

First claim

Opening claim text (preview).

The invention claimed is: 1. A therapy method for a patient having post-traumatic stress disorder (PTSD), the therapy method comprising: providing an exposure event to the patient which is related to a traumatic event that contributed to the PTSD; and providing vagus nerve stimulation to the patient electrically during a therapy session which includes the exposure event using a neurostimulator. 2. The method of claim 1 , wherein the therapy method is a memory extinction therapy method. 3. The method of claim 1 , wherein the vagus nerve stimulation has a stimulation intensity equal to or less than about 0.8 mA. 4. The method of claim 1 , wherein: the exposure event includes a trigger event; and timing of the vagus nerve stimulation is based on the trigger event. 5. The method of claim 1 , wherein the exposure event contains sensory recreations of a traumatic event. 6. The method of claim 1 , wherein the vagus nerve stimulation is performed electrically and invasively. 7. The method of claim 1 , wherein the providing an exposure event and the vagus nerve stimulation results in a reduction in symptoms of PTSD experienced by the patient. 8. The method of claim 1 , wherein the patient is a patient where the PTSD took months to develop following an initial exposure to a traumatic event that resulted in the PTSD. 9. The method of claim 1 , wherein the providing an exposure event and the vagus nerve stimulation occur long after a traumatic event that resulted in the PTSD. 10. The method of claim 1 , wherein the providing an exposure event and the vagus nerve stimulation facilitate a natural extinction process of the patient that protects most people from developing post-traumatic stress disorder. 11. The method of claim 1 , wherein the therapy method is a memory extinction therapy method, the memory extinction therapy method alleviating, at least in part, the post-traumatic stress disorder. 12. The method of claim 1 , wherein the vagus nerve stimulation has a stimulation duration of about 100 msec to about 30 sec. 13. The method of claim 1 , wherein the vagus nerve stimulation has a stimulation frequency of about 10 Hz to about 150 Hz. 14. A therapy method for a patient having a phobia disorder, therapy method comprising: providing an extinction event to the patient which is related to something that contributed to the phobia disorder; and providing vagus nerve stimulation to the patient electrically during a therapy session which includes the extinction event using a neurostimulator, thereby at least partially alleviating the phobia disorder. 15. The method of claim 14 , further comprising: executing a retention test to determine a duration of an extinction of the phobia disorder. 16. The method of claim 14 , wherein the vagus nerve stimulation is performed electrically and invasively. 17. The method of claim 14 , wherein the vagus nerve stimulation has a stimulation intensity equal to or less than about 0.8 mA. 18. The method of claim 14 , wherein a duration of the vagus nerve stimulation is about 100 msec to about 30 sec. 19. The method of claim 14 , wherein a frequency of the vagus nerve stimulation is about 10 Hz to about 150 Hz. 20. The method of claim 14 , wherein the providing an extinction event and the vagus nerve stimulation results in a reduction in symptoms of the phobia disorder experienced by the patient. 21. A therapy method for a patient having an obsessive-compulsive disorder (OCD), the therapy method comprising: providing a therapy event to the patient which is related to something that contributed to the OCD; and providing vagus nerve stimulation to the patient electrically during a therapy session which includes the therapy event using a neurostimulator. 22. The method of claim 21 , wherein the providing a therapy event includes providing an exposure event to the patient. 23. The method of claim 22 , wherein the providing a therapy event and the vagus nerve stimulation results in a reduction in symptoms of the OCD experienced by the patient. 24. The method of claim 21 , wherein the vagus nerve stimulation is performed electrically and invasively. 25. The method of claim 21 , wherein the vagus nerve stimulation has a stimulation intensity equal to or less than about 0.8 mA. 26. The method of claim 21 , wherein the vagus nerve stimulation has a stimulation duration of about 100 msec to about 30 sec. 27. The method of claim 21 , wherein the vagus nerve stimulation has a stimulation frequency of about 10 Hz to about 150 Hz. 28. A therapy method for a patient having an addiction disorder, the therapy method comprising: providing a therapy event to a patient which is related to one or more things that contributed to the addiction disorder; and providing vagus nerve stimulation to the patient electrically during a therapy session which includes the therapy event using a neurostimulator. 29. The method of claim 28 , wherein the providing a therapy event includes providing an exposure event to the patient. 30. The method of claim 29 , wherein the providing a therapy event and the vagus nerve stimulation results in a reduction in symptoms of the addiction disorder experienced by the patient. 31. The method of claim 28 , wherein the vagus nerve stimulation has a stimulation intensity equal to or less than about 0.8 mA. 32. The method of claim 28 , wherein the vagus nerve stimulation has a stimulation duration of about 100 msec to about 30 sec. 33. The method of claim 28 , wherein the vagus nerve stimulation has a stimulation frequency of about 10 Hz to about 150 Hz.

Assignees

Inventors

Classifications

  • for medicine · CPC title

  • Neuro-rehabilitation; Repair or reorganisation of neural tissue, e.g. after stroke · CPC title

  • Phantom sensations, e.g. tinnitus · CPC title

  • Mood disorders, e.g. depression, anxiety or panic disorder · CPC title

  • Mental training · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12064563B2 cover?
A therapy method (for a patient having post-traumatic stress disorder (PTSD)) includes: providing an exposure event, to the patient, which is related to a traumatic event that contributed to the PTSD; and, during a therapy session which includes the exposure event, applying vagus nerve stimulation (VNS). A therapy method (for a patient having a given disorder, e.g., a phobia disorder or an obse…
Who is the assignee on this patent?
Univ Texas, Microtransponder Inc
What technology area does this patent fall under?
Primary CPC classification A61M21/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).